Design Therapeutics, Inc. announced the initiation of a Phase 1 clinical trial for its gene-targeted treatment DT-216P2 in healthy volunteers, with patient dosing for Friedreich Ataxia (FA) set to ...

Moderna has finalized the design and dosage of its phase 3 COVID-19 vaccine trial, keeping it on track to start the pivotal test next month. Work to get the 30,000-subject phase 3 trial underway is ...

The Accelsius study, with analysis by Jacobs, indicates that two-phase direct-to-chip liquid cooling may offer up to 35% lower OpEx and 12% lower TCO compared to single-phase approaches Adoption of ...

For teams with statisticians who are not as familiar with novel dose-finding designs, there are resources for designing and conducting phase I trials, including easy-to-use software and protocol ...

Midjourney, the well-known AI art generation system and independent research lab, has announced the rollout of phase 1 of its new website design making it available on a beta subdomain for users to ...

Chemomab Therapeutics has announced that it has successfully completed its End-of-Phase 2 meeting with the FDA, aligning on the design of a single Phase 3 trial for its lead product candidate, ...

Detroit Arsenal, Mich. (Dec. 9, 2020) - Today, the U.S. Army conducted a virtual Industry Day for the Optionally Manned Fighting Vehicle (OMFV) program to provide an overview of the program’s ...